Related Experiment Videos
Effects of guanabenz therapy on renal function and body fluid composition
Archives of Internal Medicine
|June 1, 1983
Summary
Guanabenz acetate, an alpha 2-adrenergic agonist, effectively lowered blood pressure in hypertensive men. While it caused temporary reductions in kidney function, it did not alter fluid balance, showing promise as a hypertension monotherapy.
Area of Science:
- Pharmacology
- Nephrology
- Cardiovascular Medicine
Background:
- Hypertension management requires effective antihypertensive agents.
- Centrally acting alpha 2-adrenergic agonists offer a therapeutic option.
- Understanding the renal and fluid balance effects of guanabenz is crucial.
Purpose of the Study:
- To assess the impact of guanabenz acetate on renal function.
- To evaluate changes in renal hemodynamics and body fluid composition.
- To determine the efficacy and safety of guanabenz as monotherapy for hypertension.
Main Methods:
- Seventeen hypertensive men received guanabenz therapy.
- Renal function, hemodynamics, and fluid composition were assessed short-term, long-term, and during withdrawal.
- Blood pressure normalization was a prerequisite for study inclusion.
Main Results:
- Guanabenz therapy induced a modest, reversible decrease in glomerular filtration rate and renal blood flow.
- Effective renal plasma flow was reduced, but renal vascular resistance remained unchanged.
- No significant natriuretic or antinatriuretic effects were observed; a water diuresis was noted.
- Body fluid compartments showed no significant salt or water retention.
Conclusions:
- Guanabenz acetate is an effective monotherapy for hypertension in some patients.
- The observed renal function changes are reversible and do not impact fluid balance.
- Guanabenz offers a viable treatment option with manageable renal effects.